PROX1 and adenocarcinoma: Specifically, 87.5% of adenocarcinomas in the moderate-PROX1-expression group (26–50%) exhibited mucus production (14 out of 16), compared to only 25%, 30%, and 33.3% in the low (>0–25%), high (51–75%), and very high (76–100%) groups, respectively (p = 0.002).